Pneumonia among Children in Developing Countries
Links
Website for WHO publications on pneumonia, ARI, and case management of childhood illnesses http://www.who.int/chd/
References
Levine OS, Schwartz B, Pierce N, Kane M. Development, evaluation, and implementation of Hib vaccines for young children in developing countries: current status and priority actions. Pediatr Infect Dis J 1998; 17: S95-113.
Lagos R, Levine OS, Avendano A, Horwitz I, Levine MM. The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries. Pediatr Infect Dis J 1998; 17: S139-148.
Straus WL, Qazi SA, Kundi Z, Nomani NK, Schwartz B. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomized controlled trial. Lancet 1998; 352: 270-274.
Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis J 1986; 5: 247-252.
Mulholland K, Levine O, Nohynek H, Greenwood BM. Evaluation of vaccines for the prevention of pneumonia in children in developing countries. Epidemiologic Reviews 1999; 21: 43-55.
|
